2030년까지 아시아 태평양 제약 계약 판매 조직 시장 예측 - 지역 분석 - 서비스(상업 서비스 및 비상업 서비스), 모듈(신디케이트 모듈 및 전용 모듈), 치료 영역(심장혈관 장애, 종양학, 대사 장애, 신경학, 정형외과 질환)별 , 전염병 등) 및 최종 사용자(바이오의약품 회사 및 제약 회사)

아시아 태평양 의약품 계약 판매 기관 시장은 2022년 17억 748만 달러에서 2030년 36억 4688만 달러로 성장할 것으로 예상됩니다. 2022년부터 2030년까지 연평균 성장률(CAGR) 10.0%를 기록할 것으로 예상됩니다. 원격 의료 및 원격 디테일링 드라이브의 사용 증가 아시아 태평양 제약 계약 판매 조직 시장 원격 의료 및 원격 세부 사항의 사용이 증가하면서 제약 계약 판매 조직(CSO) 시장에 새로운 기회가 생겼습니다. 디지털 건강 기술의 혁신적인 영향력은 환자와 의사의 상호 작용을 재정의하고 의약품 판매 역학에 혁명을 일으켰습니다. 가상 상담 및 참여를 촉진할 수 있는 역량을 갖춘 원격 의료는 CSO가 적응하고 혁신할 수 있는 비옥한 기반을 조성합니다. 제품 정보를 전달하고 의료 전문가를 참여시키기 위해 디지털 채널을 사용하는 원격 세부 정보는 CSO가 범위를 확장할 수 있는 전략적 수단이 됩니다. 이러한 전략적 변화는 시장의 복잡성을 헤쳐나가기 위한 제약 산업의 사전 예방적 접근 방식을 강조합니다. CSO와 협력함으로써 이러한 기업은 전문 영업 인력에 접근하고 외부 전문 지식을 활용하여 시장 침투력을 높이고 영업 효율성을 향상시킬 수 있습니다. 이러한 협업 모델을 통해 제약회사는 운영을 간소화하고 연구 개발 등 핵심 역량에 집중하는 동시에 CSO의 특정 지식을 활용하여 제품의 시장성을 높일 수 있습니다. 제약회사와 CSO 간의 협력이 증가하는 것은 적응에 대한 헌신과 경쟁이 매우 치열한 제약 산업 내에서 발전하는 역학에 대한 심오한 이해를 보여줍니다. 또한 리소스 최적화에 대한 미묘한 이해를 보여줍니다. 이러한 상호 이익이 되는 파트너십을 통해 수익 극대화가 가능해지며 장기적인 성공을 위해 적응성과 집중적인 시장 전략이 필수적인 시장에 제약 회사를 전략적으로 배치할 수 있습니다. 아시아 태평양 제약 계약 판매 조직 시장 개요 아시아 태평양 제약 계약 판매 조직 시장은 비용 효율적인 판매 및 마케팅 솔루션에 대한 수요 증가로 인해 최근 몇 년 동안 상당한 성장을 경험했습니다. 제약회사는 중국, 인도, 일본 등의 국가에서 의료 제품에 대한 상당한 수요가 있음에도 불구하고 다양하고 원격 시장에 접근해야 하는 과제에 직면해 있습니다. 영업 및 마케팅 기능을 CSO에 아웃소싱함으로써 기업은 광범위한 인프라 및 인력 투자 없이도 전문 팀의 전문 지식을 활용할 수 있습니다. 또한, 아시아태평양 지역의 만성질환 증가와 고령화 인구 증가도 의약품 계약판매조직 시장 확대에 기여하고 있습니다. 디지털 기술의 가용성과 채택이 증가하고 수많은 데이터 소스에 쉽게 액세스할 수 있게 되면서 제약 CSO는 실시간 데이터를 수집하고 분석하여 고객이 실행 가능한 통찰력을 사용할 수 있도록 지원할 수 있습니다. 2023년 4월, SANOFI China는 발전하고 역동적인 비즈니스 모델에 적응할 수 있는 확장 가능하고 상업적인 편재성 CRM 솔루션을 채택하여 디지털 변혁을 가속화하고 회사가 계속해서 혁신을 향해 노력할 수 있도록 했습니다. Omnipresence CRM은 고급 분석, 데이터 소스 및 기계 학습을 사용하여 통찰력을 생성하고 더 나은 의사 결정을 지원하며 커머셜 팀이 민첩성을 높여 결과를 가속화할 수 있는 새로운 기회를 창출합니다. 아시아 태평양 제약 계약 판매 조직 시장 수익 및 2030년 예측(미화 백만 달러) 아시아 태평양 제약 계약 판매 조직 시장 세분화 아시아 태평양 제약 계약 판매 조직 시장은 서비스, 모듈, 치료 영역, 최종 사용자 및 국가로 분류됩니다. 서비스를 기반으로 아시아 태평양 제약 계약 판매 조직 시장은 상업 서비스와 비상업 서비스로 구분됩니다. 상업 서비스 부문은 2022년 아시아 태평양 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 모듈을 기준으로 아시아 태평양 제약 계약 판매 조직 시장은 신디케이트 모듈과 전용 모듈로 구분됩니다. 신디케이트된 모듈 부문은 2022년 아시아 태평양 의약품 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 치료 영역을 기준으로 아시아 태평양 의약품 계약 판매 조직 시장은 심혈관 질환, 종양학, 대사 장애, 신경학, 정형외과 질환, 감염성 질환으로 분류됩니다. 질병 및 기타. 종양학 부문은 2022년 아시아 태평양 제약 계약 판매 조직 시장에서 가장 큰 점유율을 차지했습니다. 최종 사용자를 기준으로 아시아 태평양 제약 계약 판매 조직 시장은 바이오제약 회사와 제약 회사로 구분됩니다. 제약 회사 부문은 2022년 아시아 태평양 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 국가를 기준으로 아시아 태평양 제약 계약 판매 조직 시장은 중국, 일본, 인도, 호주, 한국 및 나머지 국가로 분류됩니다. 아시아 태평양. 중국은 2022년 아시아 태평양 의약품 계약 판매 조직 시장을 장악했습니다. Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc 및 Syneos Health Inc는 다음과 같은 주요 기업 중 일부입니다. 아시아 태평양 제약 계약 판매 기관 시장.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Asia Pacific Market Analysis

6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Asia Pacific

11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 China

11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Japan

11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 India

11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.5 Australia

11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.6 South Korea

11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.7 Rest of Asia Pacific

11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 EPS Holdings Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 IQVIA Holdings Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Syneos Health Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Mednext Pharmaceuticals Pvt Ltd

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Aenova Holding GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.7 Pfizer Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market

List of Figures

Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. Asia Pacific - PEST Analysis

Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. CMIC Holdings Co Ltd

3. EPS Holdings Inc

4. IQVIA Holdings Inc

5. Mednext Pharmaceuticals Pvt Ltd

6. Pfizer Inc

7. Syneos Health Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Pharmaceutical Contract Sales Organizations Market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Asia Pacific Pharmaceutical Contract Sales Organizations Market

WHAT'S INCLUDED IN FULL REPORT